Results 11 to 20 of about 5,677 (156)

Fatty acid β‐oxidation and mitochondrial fusion are involved in cardiac microvascular endothelial cell protection induced by glucagon receptor antagonism in diabetic mice 脂肪酸β‐氧化和线粒体融合参与胰高血糖素受体拮抗剂对糖尿病小鼠心脏微血管内皮细胞的保护作用

open access: yesJournal of Diabetes, Volume 15, Issue 12, Page 1081-1094, December 2023., 2023
Highlights Glucagon receptor (GCGR) monoclonal antibody (mAb) improves cardiac function and attenuates microvascular damage in db/db mice. GCGR mAb ameliorates the oxidative stress of cardiac microvascular endothelial cells in diabetic mice. GCGR mAb counteracts the diabetes‐induced upregulation of carnitine palmitoyltransferase 1B, optic atrophy type ...
Peng Wang   +6 more
wiley   +1 more source

Cytokine transcriptome profiling in acute experimental canine atopic dermatitis skin lesions after IL‐31 inhibition with lokivetmab

open access: yesVeterinary Dermatology, Volume 34, Issue 4, Page 327-338, August 2023., 2023
Background – The caninised monoclonal antibody lokivetmab (LKV), directed at interleukin (IL)‐31, is very effective at controlling pruritus in most dogs with atopic dermatitis (AD). However, evidence exists that IL‐31 is not required for the induction of acute allergic skin inflammation, which might explain why this treatment is less efficacious in ...
Chie Tamamoto‐Mochizuki   +4 more
wiley   +1 more source

Factors that shape large‐scale gradients in clonality

open access: yesJournal of Biogeography, Volume 50, Issue 5, Page 827-837, May 2023., 2023
Abstract Aim Many plant species reproduce clonally. However, ecologists still have much to learn about the factors that shape large‐scale patterns in plant clonal growth and reproduction, especially in the southern hemisphere. We addressed this knowledge gap by quantifying relationships between reproductive mode and a suite of plant characteristics and
Hongxiang Zhang   +4 more
wiley   +1 more source

A masked, randomised clinical trial evaluating the efficacy and safety of lokivetmab compared to saline control in client‐owned dogs with allergic dermatitis

open access: yesVeterinary Dermatology, Volume 32, Issue 5, Page 477-e131, October 2021., 2021
Background – Interleukin (IL)‐31 is an important mediator in canine atopic dermatitis (cAD) and also may be dysregulated in other allergic diseases. Hypothesis/Objectives – To demonstrate the efficacy and safety of lokivetmab (canine anti‐IL‐31 monoclonal antibody) for treatment of pruritus associated with allergic dermatitis in dogs.
Leen Van Brussel   +4 more
wiley   +1 more source

Detection and Inhibition of IgE for cross‐reactive carbohydrate determinants evident in an enzyme‐linked immunosorbent assay for detection of allergen‐specific IgE in the sera of dogs and cats

open access: yesVeterinary Dermatology, Volume 31, Issue 6, Page 439-e116, December 2020., 2020
Background It has been demonstrated recently that immunoglobulin (Ig)E specific for cross‐reactive carbohydrate determinants (CCD) is present in the serum of allergen‐sensitized dogs and cats, and that these CCD‐specific antibodies might confound serological testing. Hypothesis/Objective The objective was to document the prevalence of CCD detectable in
Kenneth W. Lee   +3 more
wiley   +1 more source

Discrepancies in the bilateral intradermal test and serum tests in atopic horses

open access: yesVeterinary Dermatology, Volume 31, Issue 5, Page 390-e104, October 2020., 2020
Background – In equine atopic patients intradermal testing (IDT) and immunoglobulin (Ig)E serology are used frequently. There is little evidence regarding the reproducibility of the IDT and IgE serology in horses. Objectives – To compare the results of a simultaneously performed IDT on the left and right side of the neck in atopic horses, and to ...
Catharina M. M. van Damme   +2 more
wiley   +1 more source

Evaluation of filaggrin 2 expression in dogs with atopic dermatitis before and after oclacitinib maleate administration

open access: yesVeterinary Dermatology, Volume 36, Issue 4, Page 453-461, August 2025.
Background – Canine atopic dermatitis (cAD) is a chronic, inflammatory, multifactorial and pruritic disease. The presence of skin barrier impairment (e.g. filaggrin alterations), along with abnormal immune responses, can negatively impact cutaneous barrier function.
Wendie Roldan Villalobos   +5 more
wiley   +1 more source

Long‐term use of lokivetmab in dogs with atopic dermatitis

open access: yesVeterinary Dermatology, Volume 35, Issue 6, Page 683-693, December 2024.
Background – Lokivetmab, a caninised monoclonal antibody against interleukin (IL)‐31, is an effective treatment for the pruritus associated with canine atopic dermatitis (cAD). Objectives – To investigate the efficacy and safety of lokivetmab during long‐term treatment defined as at least three consecutive lokivetmab injections in atopic dogs under ...
Bettina Kasper   +2 more
wiley   +1 more source

Preparation and Characterization of Semaphorin3Fc Monoclonal Antibody and the Preliminary Application [PDF]

open access: yes, 2015
研究背景和目的 抑癌基因发生异常是癌症发生的机制之一。人类基因的很多区域发生改变时可导致细胞失控性生长。Sema3F作为肺癌19个候选抑癌基因之一,是Ⅲ型Semaphorin(即神经导向因子,最初作为Neuropilins的配体在神经系统中发挥排斥神经节轴突和调节神经系统发育的作用)家族的一个成员。目前有研究发现,与正常组织相比Sema3F蛋白在肿瘤细胞中的表达普遍存在下调的趋势,并在血管形成以及肿瘤增殖、凋亡、粘附和转移等中起着负向调节作用。此外,诸多体内或者体外实验已经证明 ...
李哲
core  

尖吻蝮蛇蛇毒纤溶因子单克隆抗体的制备

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 1999
目的: 制备从尖吻蝮蛇蛇毒中分离的纤溶因子的单克隆抗体, 为克隆基因提供特异性的探针。方法: 将纤溶因 子免疫 Balb/C 小鼠,取脾细胞与 SP 2/0 骨髓瘤细胞融合, 筛选稳定分泌抗体的细胞株。采用血纤维蛋白平板法,观察单克隆 抗体能否抑制纤溶因子的纤溶作用。结果: 获得 2 株稳定分泌单克隆抗体的细胞株。 Western 印迹显示该单克隆抗体能特异 地与纤溶因子结合,与其它蛋白无交叉反应, 此外,这 2株单克隆抗体具有抑制纤溶因子溶解人血纤维蛋白的作用。结论: 这 2 ...
邱鹏新 黎明涛 苏兴文 陈家树 颜光美
doaj  

Home - About - Disclaimer - Privacy